Escitalopram-associated rhabdomyolysis

Tidsskr Nor Laegeforen. 2023 Aug 24;143(12). doi: 10.4045/tidsskr.23.0093. Print 2023 Sep 5.ABSTRACTThis case history describes a case of rhabdomyolysis resulting from treatment with escitalopram as monotherapy at the recommended dose. This is a rare and little-known side effect of selective serotonin reuptake inhibitors.PMID:37668131 | DOI:10.4045/tidsskr.23.0093

Source: Tidsskrift for den Norske Laegeforening - September 5, 2023 Category: General Medicine Authors: Kamilla Kvikstad Mathisen Randolf Hardersen Source Type: research